Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial

Background. The evidence base regarding the safety of intravenous (IV) iron therapy in patients with chronic kidney disease (CKD) is incomplete and largely based on small studies of relatively short duration. Methods. FIND-CKD (ClinicalTrials.gov number NCT00994318) was a 1-year, open-label, multice...

Descripción completa

Detalles Bibliográficos
Autores principales: Roger, Simon D., Gaillard, Carlo A., Bock, Andreas H., Carrera, Fernando, Eckardt, Kai-Uwe, Van Wyck, David B., Cronin, Maureen, Meier, Yvonne, Larroque, Sylvain, Macdougall, Iain C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837517/
https://www.ncbi.nlm.nih.gov/pubmed/28339831
http://dx.doi.org/10.1093/ndt/gfw264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837517/
https://www.ncbi.nlm.nih.gov/pubmed/28339831
http://dx.doi.org/10.1093/ndt/gfw264

Ejemplares similares